Literature DB >> 28341230

Intraoperative cryoanalgesia for managing pain after the Nuss procedure.

Claire Graves1, Olajire Idowu1, Sang Lee2, Benjamin Padilla1, Sunghoon Kim3.   

Abstract

BACKGROUND: Cryoanalgesia prevents pain by freezing the affected peripheral nerve. We report the use of intraoperative cryoanalgesia during the Nuss procedure for pectus excavatum and describe our initial experience, modifications of technique, and lessons learned.
MATERIALS AND METHODS: We retrospectively reviewed the medical records of patients who received cryoanalgesia during the Nuss procedure between June 1, 2015, and April 30, 2016, at our institutions and analyzed modifications in surgical technique during this early adoption period.
RESULTS: Eight male and two female patients underwent the Nuss procedure with cryoanalgesia. The mean postoperative length of stay (LOS) was 2days (range 1-3). Average inpatient pain scores were 3.4, 3.2, and 4.6 on postoperative days 1-3, respectively (N=10, 7, and 2). At a 1-week postoperative visit, mean pain score was 1.1 (N=6). Compared to the preceding 15 Nuss patients at our institution, who were treated with a thoracic epidural, postoperative LOS was significantly shorter with cryoanalgesia (2.0±0.82 vs. 6.3±1.3days, P<0.001). We modified our technique for patient habitus and adopted single-lung ventilation for improved visualization.
CONCLUSIONS: Cryoanalgesia may be the ideal pain management strategy for Nuss patients because it is effective and long lasting. Intraoperative application is easily integrated into the Nuss procedure. STUDY TYPE: Treatment study: case series; Evidence level IV.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cryoanalgesia; Cryoprobe; Epidural analgesia; Nuss procedure; Pectus excavatum

Mesh:

Year:  2017        PMID: 28341230     DOI: 10.1016/j.jpedsurg.2017.03.006

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  7 in total

1.  Intraoperative intercostal nerve cryoablation During the Nuss procedure reduces length of stay and opioid requirement: A randomized clinical trial.

Authors:  Claire E Graves; Jarrett Moyer; Michael J Zobel; Roberto Mora; Derek Smith; Maura O'Day; Benjamin E Padilla
Journal:  J Pediatr Surg       Date:  2019-03-17       Impact factor: 2.545

2.  Extended pain relief achieved by analgesic-eluting biodegradable nanofibers in the Nuss procedure: in vitro and in vivo studies.

Authors:  Kuo-Sheng Liu; Wei-Hsun Chen; Cheng-Hung Lee; Yong-Fong Su; Shih-Jung Liu
Journal:  Int J Nanomedicine       Date:  2018-12-07

3.  Surgical Stabilization of Rib Fractures: Indications, Techniques, and Pitfalls.

Authors:  Alexander A Fokin; Nir Hus; Joanna Wycech; Eugenio Rodriguez; Ivan Puente
Journal:  JBJS Essent Surg Tech       Date:  2020-05-07

4.  A New Device for Thoracoscopic Cryoanalgesia in Pectus Excavatum Repair: Preliminary Single Center Experience.

Authors:  Michele Torre; Leila Mameli; Rachele Bonfiglio; Vittorio Guerriero; Lucia Derosas; Loredana Palomba; Nicola Disma
Journal:  Front Pediatr       Date:  2021-01-18       Impact factor: 3.418

5.  Implementation of an Enhanced Recovery Pathway for Minimally Invasive Pectus Surgery: A Population-Based Cohort Study Evaluating Short- and Long-Term Outcomes Using eHealth Technology.

Authors:  Davina Wildemeersch; Michiel D'Hondt; Lisa Bernaerts; Pieter Mertens; Vera Saldien; Jeroen Mh Hendriks; Anne-Sophie Walcarius; Lutgard Sterkens; Guy H Hans
Journal:  JMIR Perioper Med       Date:  2018-10-12

6.  Limited cryoablation reduces hospital stay and opioid consumption compared to thoracic epidural analgesia after minimally invasive repair of pectus excavatum.

Authors:  Seung Hwan Song; Duk Hwan Moon; Yon Hee Shim; Hyunjoo Jung; Sungsoo Lee
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

7.  Intercostal nerve cryoablation for control of traumatic rib fracture pain: A case report.

Authors:  John D Vossler; Frank Z Zhao
Journal:  Trauma Case Rep       Date:  2019-07-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.